128 related articles for article (PubMed ID: 1325045)
1. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome.
Rizzo JF; Gittinger JW
Ophthalmology; 1992 Aug; 99(8):1286-95. PubMed ID: 1325045
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
Murphy MA; Thirkill CE; Hart WM
J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
[TBL] [Abstract][Full Text] [Related]
4. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
5. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
6. [Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor].
Holz FG; Bellmann C; Steffen H; Nölle B; Huober J; Krastel H; Alexandridis E
Ophthalmologe; 1997 May; 94(5):337-42. PubMed ID: 9273033
[TBL] [Abstract][Full Text] [Related]
7. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
8. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
9. The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.
Eichen JG; Dalmau J; Demopoulos A; Wade D; Posner JB; Rosenfeld MR
J Neuroophthalmol; 2001 Sep; 21(3):168-72. PubMed ID: 11725181
[TBL] [Abstract][Full Text] [Related]
10. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic retinopathy simulating cone dystrophy with achromatopsia].
Cogan DG; Kuwabara T; Currie J; Kattah J
Klin Monbl Augenheilkd; 1990 Aug; 197(2):156-8. PubMed ID: 2243476
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
13. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
Khan N; Huang JJ; Foster CS
Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
[TBL] [Abstract][Full Text] [Related]
14. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
Bazhin AV; Dalke C; Willner N; Abschütz O; Wildberger HG; Philippov PP; Dummer R; Graw J; de Angelis MH; Schadendorf D; Umansky V; Eichmüller SB
Int J Cancer; 2009 Jan; 124(1):140-9. PubMed ID: 18814277
[TBL] [Abstract][Full Text] [Related]
15. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
Dot C; Guigay J; Adamus G
Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
Keltner JL; Thirkill CE; Yip PT
J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.
Peek R; Dijkstra BG; Meek B; Kuijpers RW
Clin Exp Immunol; 2002 Jun; 128(3):498-503. PubMed ID: 12067305
[TBL] [Abstract][Full Text] [Related]
19. A clinical triad to diagnose paraneoplastic retinopathy.
Jacobson DM; Thirkill CE; Tipping SJ
Ann Neurol; 1990 Aug; 28(2):162-7. PubMed ID: 2171418
[TBL] [Abstract][Full Text] [Related]
20. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
